We are live on ! Find out more
JAGX icon

Jaguar Health
JAGX

3 hedge funds and large institutions have $35.2K invested in Jaguar Health in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 2 → 3 (+1)

43% more capital invested

Capital invested by funds: $24.6K → $35.2K (+$10.6K)

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$38.3K
2
TRCT
Tower Research Capital (TRC)
New York
+$8.21K

Top Sellers

Rank Fund Capital Flow
1
DB
Danske Bank
Denmark
-$10

JAGX Hedge Fund Activity: Q2 2025 in Review

3 of the 7,617 institutional investors tracked by Wall St. Rank reported a position in Jaguar Health (JAGX) for Q2 2025, worth a combined $35.2K — up 43% from $24.6K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new JAGX positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $38.3K. The largest seller was Danske Bank, cutting an estimated $10.

  • 3 institutional investors held Jaguar Health (JAGX) as of Q2 2025, up from 2 in Q1 2025.
  • Funds reported $35.2K of Jaguar Health stock for Q2 2025, up 43% quarter-over-quarter.
  • 1 fund opened new Jaguar Health positions in Q2 2025 and 0 closed out, a net change of +1 holder.
  • The largest Jaguar Health buyer in Q2 2025 was UBS Group, an estimated $38.3K added.
  • The largest Jaguar Health seller in Q2 2025 was Danske Bank, an estimated $10 sold.

Based on aggregated 13F filings for Q2 2025.